Punjab Health Minister Balbir Singh Sidhu on Saturday said he will file a defamation suit against Akali leader Bikram Singh Majithia for allegedly levelling false allegations against him in connection with the diversion of buprenorphine tablets from private de-addiction centres (PDAC).
Speaking in the Punjab Assembly on Wednesday, Majithia had sought Sidhu's dismissal from the cabinet, alleging that five crore tablets of buprenorphine, a scheduled drug, worth Rs 200 crore had gone missing from the PDCAs.
Describing Majithia's allegations as "baseless and fallacious", Sidhu said he will file a defamation suit against the Shiromani Akali Dal (SAD) leader.
The previous SAD-BJP government "totally failed" to break the supply line of drugs and now the Akalis are trying to divert people's attention by politicising the issue, the health minister said.
Sidhu said the PDACs are authorised to directly purchase medicines from pharmaceutical companies and the health department has no role in the process.
The difference in online and offline records of medicines was noticed by the health department itself. After that, to ensure 100 per cent data entry online, show cause notices have been issued to the PDACs, he added.
Sidhu said he has directed Principal Secretary Anurag Aggarwal to conduct a thorough audit of all the PDACs.
He said he has also asked Aggarwal to ensure that treatment of patients is not affected during the audit.
He added that he is personally monitoring the issue and legal action will be taken after an analysis of the online and offline records of the PDACs.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
